Scope and efficiency of the newborn screening program in identifying hemoglobin S

Abstract

BackgroundIn 2001, the Brazilian Ministry of Health added hemoglobinopathies to the National Neonatal Screening Program to be implemented in three steps. In order to meet the proposed goals, it is crucial to establish periodic assessments of this program with the aim of monitoring its implementation.ObjectiveTo assess the scope and the efficiency of the stages of the National Newborn Screening Program in identifying hemoglobin S.MethodsA cross-sectional study was developed with the results of the heel prick test using the high performance liquid chromatography method for babies born in Mato Grosso do Sul from 2006 to 2010. The following variables were investigated: year, number of live births, total screening, coverage ratio, prevalence, time between the child birth and the blood collection; age at diagnosis; age at the time of the first consultation; and time between the diagnosis and the first appointment.ResultsOver the five years of the study, the mean coverage rate was 91.77%. The prevalences of hemoglobin FAS and hemoglobin FS were 1.65% and 0.011%, respectively. Blood samples from 43.48% of children were collected from the second to the seventh day. The age at diagnosis was within the first 28 days in 87.80% of the screened children. The lowest mean indices for the first consultation and the time between the diagnosis and the first appointment (58.8 and 46.4 days, respectively) occurred in 2010.ConclusionsThe scope of the National Neonatal Screening Program for hemoglobinopathies is good, with a large number of individuals being tested. Efficiency is a suitable indicator to assess the program steps. Three points are recommended: the training of the individuals involved, studies to assess the assistance provided to the affected child, and genetic counseling to the mothers.© 2014 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. All rights reserved.

Pattern of Hemoglobinopathies among Patients Attending PHC in Riyadh, Saudi Arabia

“…The predominance of the S/S genotype in our study mirrors findings from other hemoglobinopathy-endemic regions, emphasizing the global burden of sickle cell disease and the need for targeted preventive measures [24,25]. Similarly, the association between age groups and HGB types observed in our study corroborates evidence from existing literature, suggesting age-related variations in the prevalence of hemoglobinopathies [26,27]. However, discrepancies in the association between gender, nationality, and HGB types underscore the complex interplay of genetic, environmental, and sociodemographic factors influencing the distribution of hemoglobinopathies.…”

Análise geoespacial e propagação da Doença Falciforme (HbAS e HbS) em Mato Grosso do Sul, Brasil

“…Brazilian Journal of Health Review, Curitiba, v. 5, n. 4, p. 13424-13434, jul./aug., 2022 A AF (HbSS) é considerada a forma grave da doença 5 . As principais características clínicas dessa doença podem ser alocadas em dois principais grupos de eventos: os de vasooclusão e os de hemólise crônica 6 .…”

Pesquisa De Hemoglobinas Variantes Na População De Francisco Beltrão – Paraná

“…A HbA2 composta de duas cadeias proteicas alfa e duas delta (δ), representa de 2 a 3,7% da quantidade total de Hb, enquanto a Hb Fetal (HbF) formada por duas cadeias alfa e duas cadeias gama (γ) representa de 0 a 1,5%, das Hb circulantes. 3,4 Os defeitos genéticos das hemoglobinas, denominados hemoglobinopatias, constituem um grupo de alterações autossômicas, na maioria das vezes recessivas e são as doenças genéticas mais comuns em todo o mundo, com mais de 1.000 12,20 .…”